Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of €39.04 and traded as high as €41.10. Fresenius Medical Care shares last traded at €41.03, with a volume of 606,370 shares traded.
Fresenius Medical Care Price Performance
The business’s 50 day moving average price is €38.33 and its two-hundred day moving average price is €39.04. The stock has a market cap of $12.20 billion, a P/E ratio of 18.51, a price-to-earnings-growth ratio of 0.42 and a beta of 0.82. The company has a current ratio of 1.20, a quick ratio of 0.80 and a debt-to-equity ratio of 83.29.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Stories
- Five stocks we like better than Fresenius Medical Care
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
